EU Pharmacovigilance Impact of the New Regulation

Quantity Discounts
1 - 9999
1 - 9999
1 - 9999
1 - 9999
1 - 9999
1 - 9999
1 - 9999
1 - 9999

More than 15 significant new pharmacovigilance requirements have been introduced in the EU in the past year.  Many changes will require drugmakers to make process changes and have prompted such questions as:

  • How is the newly formed PRAC operating?
  • What impact will the new PRAC, Periodic Safety Update Report/Periodic Benefit-Risk Evaluation Report (PSUR/PBRER) and Risk Management Plan (RMP) requirements have on your operations?
  • How will changes in the legislation affect the way product assessment is carried out in both pre- and post- authorization phases?
  • How will CMDh and other committees interact with the PRAC?
  • Will the black symbol requirements radically change your product information processes?
For answers to these questions and more….

Register Today

FDAnews and noted EU pharmacovigilance expert Elisabethann Wright of Brussels-based Hogan Lovells have teamed up to provide an update on the status of pharmacovigilance in the EU.

In 90 minutes, Ms. Wright will guide you through the most immediate changes and the layers of regulation to focus on the key requirements.

This will not be taught in regulation-speak, or legalese.  Ms. Wright will provide attendees with real world and easy-to-use guidance that makes the regulations understandable.

Mark your calendar now for this important 90-minute webinar on Tuesday, Sept. 25. It couldn’t be easier to attend: simply make sure you’re in front of a screen at the appointed time, and you’ll benefit from all the great advice in EU Pharmacovigilance without having to leave your workplace.

Everyone in your organization with a role in pharmacovigilance — clinical safety, medical affairs and regulatory affairs — should take part in this event and they can do so at a cost that won’t break the budget. You pay a single low registration fee per phone line, regardless of how many participate. So spread the word.

Have questions? Simply submit them online during the event or via email for answers by the time the session ends.

Register now.

This is a must-attend session for anyone involved in EU pharmacovigilance, including:

  • Medical affairs officers
  • Regulatory affairs professionals
  • In-house regulatory specialists
  • External regulatory specialists 
  • Lawyers responsible for pharmacovigilance
  • Medical directors/medical affairs specialists
  • Global clinical safety and pharmacovigilance officers

Elisabethann Wright, BL, is a partner in the Brussels, Belgium, office of Hogan Lovells International.  Her experience in the area of European law has included both periods in private practice and periods working with international institutions. She focuses on European Union (EU) law relating to life sciences, with particular emphasis on pharmaceutical law, medical devices, food law and the environment. This includes assisting clients in classification of their products, establishment of a pathway to authorization and marketing of their products in the EU (including related regulatory obligations), pharmacovigilance obligations, promotion and marketing of products, sales agreements, clinical trial agreements, adverse event reporting, product withdrawals and challenges to national authority, and EU Institution decisions concerning classification and marketing of medicinal products and medical devices. 

Register now!

Date: Wednesday, Sept. 25, 2013
Location: Your office or conference room (no need to travel!)
Time: 11:00 a.m. – 12:30 p.m. EDT
  10:00 a.m. – 11:30 a.m. CDT
  9:00 a.m. – 10:30 a.m. MDT
  8:00 a.m. – 9:30 a.m. PDT
  4:00 p.m. – 5:30 p.m. BST

Gather your team for maximum benefit! Your investment is for one dial-in.

Interested in registering multiple sites?

Significant tuition discounts are available for three or more sites from
the same company. You must register at the same time and
provide a single payment to take advantage of the discount. Register below
by clicking on add to cart and then change your quantity in the shopping cart.
The discount will be calculated automatically.

3-4 sites – 10%
7-9 sites – 20%
5-6 sites – 15%
10+ sites – 25%

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
with any questions.

Check your local time against the times above. (Washington, D.C. is representative of Eastern time.)

Can't make the scheduled date and time? See the 24/7 ENCORE option described below.

Five Cost-Effective Tuition Options
All participants of the live session are eligible to receive a certificate of attendance.

Payment is required by the date of the webinar. We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.

Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Webinar registrations may not be cancelled. Registrants may substitute the 24/7 ENCORE™ audio presentation or the CD/transcript package for the live webinar at any time. Please contact customer service to make any substitutions. No shows will automatically be shipped the CD/transcript package, including the speaker's presentation. (Additional shipping and handling charges for the CD/transcript package may apply.)

Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.